Sol-Gel Technologies Ltd.

Address
7 Golda Meir

Sponsor Overview

assignment
1
sponsored trial
science
1
molecule
location_city
14
research centres
public
6
countries
person_search
12
investigators

Specializations

Gorlin syndrome and basal cell carcinoma prevention

Clinical research is centered on Gorlin syndrome, with attention to preventing basal cell carcinomas on the face and addressing the dermatologic burden associated with this inherited condition.

  • Facial basal cell carcinoma prevention
  • Inherited cancer predisposition
  • Dermatologic oncology

The sponsor’s activity reflects a focused interest in skin cancer management within a rare genetic disorder affecting the face and other sun-exposed areas.

Topical dermatologic therapy

Research interest includes topical treatment for skin disease, with emphasis on a gel formulation designed for facial application in adults with Gorlin syndrome.

  • Topical gel delivery
  • Facial skin treatment
  • Cutaneous lesion control

This area highlights therapeutic focus on localized dermatologic intervention rather than systemic disease management.

Rare disease dermatology

The sponsor’s clinical activity is aligned with rare disease care, particularly conditions where skin tumor risk and long-term dermatologic surveillance are central clinical concerns.

  • Rare genetic skin disorders
  • Cutaneous tumor prevention
  • Long-term dermatologic management

Clinical interest is concentrated on a single therapeutic domain involving prevention of recurring skin cancers in a genetically defined population.

Sponsored Trials

Trial Name Country Status
Phase 3 Study of Patidegib Gel 2% for Basal Cell Carcinoma Reduction in Gorlin Syndrome PatientsFrance FranceGermany GermanyItaly ItalyPoland PolandSpain SpainThe Netherlands The NetherlandsNot Recruiting

Data & Insights

science
Molecule Portfolio
Compounds under investigation
1
Exclusive Molecules
out of 1 total (100% not shared with other sponsors)

This sponsor works with 1 molecule, of which 1 is not being studied by other sponsors.

hub
Site Partnerships
Collaboration with research centres
0%
Return partnership rate
0 of 14 sites collaborated multiple times

This sponsor has worked with 14 sites across their trial portfolio.

Therapeutic Focus

  • 1.
    Congenital, Hereditary, and Neonatal Diseases and Abnormalities1 trial
    165 other sponsors

Partnered Research Centres

14 centres
location_city
assignment244
Azienda Ospedaliero-Universitaria Maggiore Della Carita
Address
Corso Giuseppe Mazzini 18, 28100 Novara
Learn morearrow_forward
location_city
assignment1199
Centre Hospitalier Lyon Sud
Address
165 Chemin Du Grand Revoyet, 69310 Pierre Benite
Learn morearrow_forward
location_city
assignment1093
Centre Hospitalier Universitaire De Nantes
Address
1 Place Alexis Ricordeau, 44000 Nantes
Learn morearrow_forward
location_city
assignment1047
Charite Universitaetsmedizin Berlin KöR
Address
Hindenburgdamm 30, Lichterfelde, 12203 Berlin
Learn morearrow_forward
location_city
assignment50
Dermoklinika - Centrum Medyczne s.c. M. Kierstan J. Narbutt A. Lesiak
Address
Al. Tadeusza Kościuszki 93, 90-436 Lodz
Learn morearrow_forward
location_city
assignment12
Deutsches Rotes Kreuz Gemeinnuetzige Krankenhaus GmbH Sachsen
Address
Unritzstrasse 23, Rabenstein, 09117 Chemnitz
Learn morearrow_forward
Page 1 of 3

Want to get in touch with this sponsor?

Send a question and we'll pass it on to Sol-Gel Technologies Ltd..

Need a custom report on this sponsor?

Competitive positioning, market entry, partnership opportunities — tell us the question.

Is something out of date?

Tell us what needs correcting and we'll update this profile.